Christopher Muller joins QLT as CCO
This article was originally published in Scrip
QLT, a biotech developing innovative ocular products, has named Christopher Muller chief commercial officer of QLT Opthalmics, the company's US commercial operations subsidiary. He will report to Bob Butchofsky, QLT's president and CEO. Most recently Mr Muller was head of corporate strategy and key opinion leaders at Abbott Medical Optics, a wholly owned subsidiary of Abbott Laboratories.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.